{"title":"A multimodal contrastive learning framework for predicting P-glycoprotein substrates and inhibitors.","authors":"Yixue Zhang, Jialu Wu, Yu Kang, Tingjun Hou","doi":"10.1016/j.jpha.2025.101313","DOIUrl":null,"url":null,"abstract":"<p><p>P-glycoprotein (P-gp) is a transmembrane protein widely involved in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of drugs within the human body. Accurate prediction of P-gp inhibitors and substrates is crucial for drug discovery and toxicological assessment. However, existing models rely on limited molecular information, leading to suboptimal model performance for predicting P-gp inhibitors and substrates. To overcome this challenge, we compiled an extensive dataset from public databases and literature, consisting of 5,943 P-gp inhibitors and 4,018 substrates, notable for their high quantity, quality, and structural uniqueness. In addition, we curated two external test sets to validate the model's generalization capability. Subsequently, we developed a multimodal graph contrastive learning (GCL) model for the prediction of P-gp inhibitors and substrates (MC-PGP). This framework integrates three types of features from Simplified Molecular Input Line Entry System (SMILES) sequences, molecular fingerprints, and molecular graphs using an attention-based fusion strategy to generate a unified molecular representation. Furthermore, we employed a GCL approach to enhance structural representations by aligning local and global structures. Extensive experimental results highlight the superior performance of MC-PGP, which achieves improvements in the area under the curve of receiver operating characteristic (AUC-ROC) of 9.82% and 10.62% on the external P-gp inhibitor and external P-gp substrate datasets, respectively, compared with 12 state-of-the-art methods. Furthermore, the interpretability analysis of all three molecular feature types offers comprehensive and complementary insights, demonstrating that MC-PGP effectively identifies key functional groups involved in P-gp interactions. These chemically intuitive insights provide valuable guidance for the design and optimization of drug candidates.</p>","PeriodicalId":94338,"journal":{"name":"Journal of pharmaceutical analysis","volume":"15 8","pages":"101313"},"PeriodicalIF":8.9000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12409376/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical analysis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jpha.2025.101313","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/16 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
P-glycoprotein (P-gp) is a transmembrane protein widely involved in the absorption, distribution, metabolism, excretion, and toxicity (ADMET) of drugs within the human body. Accurate prediction of P-gp inhibitors and substrates is crucial for drug discovery and toxicological assessment. However, existing models rely on limited molecular information, leading to suboptimal model performance for predicting P-gp inhibitors and substrates. To overcome this challenge, we compiled an extensive dataset from public databases and literature, consisting of 5,943 P-gp inhibitors and 4,018 substrates, notable for their high quantity, quality, and structural uniqueness. In addition, we curated two external test sets to validate the model's generalization capability. Subsequently, we developed a multimodal graph contrastive learning (GCL) model for the prediction of P-gp inhibitors and substrates (MC-PGP). This framework integrates three types of features from Simplified Molecular Input Line Entry System (SMILES) sequences, molecular fingerprints, and molecular graphs using an attention-based fusion strategy to generate a unified molecular representation. Furthermore, we employed a GCL approach to enhance structural representations by aligning local and global structures. Extensive experimental results highlight the superior performance of MC-PGP, which achieves improvements in the area under the curve of receiver operating characteristic (AUC-ROC) of 9.82% and 10.62% on the external P-gp inhibitor and external P-gp substrate datasets, respectively, compared with 12 state-of-the-art methods. Furthermore, the interpretability analysis of all three molecular feature types offers comprehensive and complementary insights, demonstrating that MC-PGP effectively identifies key functional groups involved in P-gp interactions. These chemically intuitive insights provide valuable guidance for the design and optimization of drug candidates.
p -糖蛋白(P-gp)是一种跨膜蛋白,广泛参与药物在人体内的吸收、分布、代谢、排泄和毒性作用(ADMET)。准确预测P-gp抑制剂和底物对药物发现和毒理学评估至关重要。然而,现有的模型依赖于有限的分子信息,导致预测P-gp抑制剂和底物的模型性能不理想。为了克服这一挑战,我们从公共数据库和文献中编译了一个广泛的数据集,包括5,943个P-gp抑制剂和4,018个底物,以其高数量、高质量和结构独特性而闻名。此外,我们策划了两个外部测试集来验证模型的泛化能力。随后,我们开发了一个多模态图对比学习(GCL)模型,用于预测P-gp抑制剂和底物(MC-PGP)。该框架集成了简化分子输入线输入系统(SMILES)序列、分子指纹和分子图三种类型的特征,使用基于注意力的融合策略来生成统一的分子表示。此外,我们采用了GCL方法,通过对齐本地和全局结构来增强结构表示。大量的实验结果突出了MC-PGP的优越性能,与12种最先进的方法相比,MC-PGP在外部P-gp抑制剂和外部P-gp底物数据集上的受试者工作特征曲线下面积(AUC-ROC)分别提高了9.82%和10.62%。此外,对所有三种分子特征类型的可解释性分析提供了全面和互补的见解,表明MC-PGP有效地识别了参与P-gp相互作用的关键功能基团。这些化学直观的见解为候选药物的设计和优化提供了有价值的指导。